Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Nevalainen

Helena Nevalainen, New South Wales AU

Patent application numberDescriptionPublished
20080233612Fungal Hosts for Expression of Recombinant Products - An isolated mutant 09-25-2008

Kaisu Milja Helena Nevalainen, New South Wales AU

Patent application numberDescriptionPublished
20110053218MULTIPLE PROMOTER PLATFORM FOR PROTEIN PRODUCTION - A multiple promoter platform for expression of a protein or multiple and different proteins in a microorganism comprising two or more expression vectors having a nucleic acid molecule encoding a protein to be expressed, or having different nucleic acid molecules encoding different proteins to be expressed, wherein each vector has a different promoter operably linked to the nucleic acid molecule, and uses of the multiple promoter platform to produce recombinant proteins.03-03-2011

Kimmo Nevalainen, Kotka FI

Patent application numberDescriptionPublished
20090186135HEAT-SEALED STERILISED PRODUCT PACKAGE, PACKAGING MATERIAL FOR THE SAME AND USE OF THE PACKAGING MATERIAL - The invention relates to a polymer-coated heat-sealable packaging material, to a heat-sterilised package formed from this and to the use of the packaging material. The material comprises a fibre base 07-23-2009
20090258119POLYMER-COATED LIQUID PACKAGING BOARD, A PACKAGE FORMED FROM IT AND THE USE OF THE POLYMER - The object of the invention is a liquid packaging board (10-15-2009
20090324861POLYMER-COATED HEAT-SEALABLE PACKAGING MATERIAL AND A SEALED PACKAGE MANUFACTURED THEREOF - The invention relates to a heat-sealable packaging material and a sealed package formed from the same, especially for packaging foodstuffs. The packaging material comprises a base layer of paper or board and polymeric heat-sealable layers on one side of the base layer or, preferably, on both sides thereof. According to the invention, at least two layers of ethylene vinyl alcohol copolymer (EVOH) with different fractions of ethylene monomer are arranged on the packaging material to provide an oxygen barrier. The layers can locate against each other without a tie layer between them. The heat-sealable polymer can be a polyolefin, and, in addition, other polymeric barrier layers can be incorporated into the material to improve its oxygen, fat and aroma tightness.12-31-2009

Marja T. Nevalainen, Annandale, VA US

Patent application numberDescriptionPublished
20100120892METHODS AND COMPOSITIONS FOR THE INHIBITION OF STAT5 IN PROSTATE CANCER CELLS - The present invention relates to compositions and methods for the treatment of prostate cancer. In certain embodiments, the invention relates to compositions and methods for the inhibition of prostate cancer cell growth, comprising inhibiting the activity of Stat5 in prostate cancer cells.05-13-2010

Marta Nevalainen, Weymouth, MA US

Patent application numberDescriptionPublished
20110274654TRIAZOLES AS INHIBITORS OF FATTY ACID SYNTHASE - Provided herein are triazole FASN inhibitors of the formula (I):11-10-2011

Marta Nevalainen, Quincy, MA US

Patent application numberDescriptionPublished
20080269272CYCLOPAMINE ANALOGUES AND METHODS OF USE THEREOF - The present invention provides compositions and methods for modulating smoothened-dependent pathway activation. The present invention provides analogs of cyclopamine that can be used to counteract the phenotypic effects of unwanted activation of a hedgehog pathway, such as resulting from hedgehog gain-of-function, Ptc loss-of-function or smoothened gain-of-function mutations. The compounds of the present invention are particularly useful in treating cancers.10-30-2008
20110166353Cyclopamine Analogues and Methods of Use Thereof - The present invention provides compositions and methods for modulating smoothened-dependent pathway activation. The present invention provides analogs of cyclopamine that can be used to counteract the phenotypic effects of unwanted activation of a hedgehog pathway, such as resulting from hedgehog gain-of-function, Ptc loss-of-function or smoothened gain-of-function mutations. The compounds of the present invention are particularly useful in treating cancers.07-07-2011
20110213145Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners - The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.09-01-2011

Patent applications by Marta Nevalainen, Quincy, MA US

Marta Nevalainen, Weymoutn, MA US

Patent application numberDescriptionPublished
20110274655TETRAZOLONES AS INHIBITORS OF FATTY ACID SYNTHASE - Provided herein are tetrazolone FASN inhibitors of the formula (I):11-10-2011

Tapio Nevalainen, Hiltulanlahti FI

Patent application numberDescriptionPublished
20090118480Novel Quaternary Polymers - The present invention relates to novel quaternized polymers, especially of chitin/chitosan type, and to carbohydrate polymers carrying quaternized ammonium groups, especially piperazinium groups. Such polymers are characterized i.a. by improved solubility characteristics.05-07-2009

Teemu Nevalainen, Varkaus FI

Patent application numberDescriptionPublished
20120134882Fluidized Bed Reactor - A fluidized bed reactor includes a bottom portion, a roof portion and side walls vertically extending between the bottom portion and the roof portion, forming a reaction chamber of the fluidized bed reactor. A solids separator is in connection with the reaction chamber. At least one side wall of the reaction chamber forms at least one indentation in the reaction chamber, which indentation is substantially vertical and extends from the plane of the side wall towards the reaction chamber.05-31-2012

Vesa Nevalainen, Weymouth, MA US

Patent application numberDescriptionPublished
20110274654TRIAZOLES AS INHIBITORS OF FATTY ACID SYNTHASE - Provided herein are triazole FASN inhibitors of the formula (I):11-10-2011
20110274655TETRAZOLONES AS INHIBITORS OF FATTY ACID SYNTHASE - Provided herein are tetrazolone FASN inhibitors of the formula (I):11-10-2011